Perspectives and prospectives in the management of acute leukemia.
D001500:BCG Vaccine; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D007938:Leukemia / Q000652:urine; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000628:therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000628:therapy*; D008017:Life Expectancy; D009163:Mycobacterium bovis / Q000276:immunology; D009712:Nucleotides, Cyclic / Q000652:urine; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use
D001500:BCG Vaccine; D009712:Nucleotides, Cyclic; D003561:Cytarabine; D014750:Vincristine; D011241:Prednisone; D003630:Daunorubicin